Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing

Joseph B. Hiatt(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David MacPherson(University of Washington)
Clinical Cancer Research
August 2, 2022
10.1158/1078-0432.ccr-22-1128
Cited by 115

Related Papers

Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation
|Genome Research|2013|347
<i>MYCN</i> drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity
|Genes & Development|2020|89
A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence
|Journal of Clinical Investigation|2017|48
Cooperation between Rb and Arf in suppressing mouse retinoblastoma
|Journal of Clinical Investigation|2012|24